Andrew H. Limper
Impact in
- Infectious Diseases top 0.2%
- Antifungal resistance and susceptibility
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Epidemiology top 0.1%
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
- Fungal Infections and Studies
Papers in
- Epidemiology 164
- Pneumocystis jirovecii pneumonia detection and treatment 150
- Pneumonia and Respiratory Infections 53
- Fungal Infections and Studies 22
-
- Antifungal resistance and susceptibility 45
- Tuberculosis Research and Epidemiology 30
- HIV/AIDS drug development and treatment 27
- Co-authors
- Charles F. Thomas (22 shared papers)Joseph E. Standing (19 shared papers)Thomas V. Colby (9 shared papers)Theodore J. Kottom (73 shared papers)Robert Vassallo (21 shared papers)Eva M. Carmona (37 shared papers)Steven H. Yale (1 shared paper)Edward B. Leof (19 shared papers)
- Journals
- CHEST Journal (22 papers)Infection and Immunity (17 papers)American Journal of Respiratory Cell and Molecular Biology (17 papers)American Journal of Respiratory and Critical Care Medicine (13 papers)The Journal of Immunology (9 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Andrew H. Limper
283 papers receiving 14.2k citations
Andrew H. Limper's Hit Papers
Peers
Comparison fields: 5 of 160
- Infectious Diseases 3.7k
- Epidemiology 6.1k
- Pulmonary and Respiratory Medicine 4.3k
- Immunology 1.3k
- Physiology 1.5k
Countries citing papers authored by Andrew H. Limper
This map shows the geographic impact of Andrew H. Limper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Limper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Limper more than expected).
Fields of papers citing papers by Andrew H. Limper
This network shows the impact of papers produced by Andrew H. Limper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Limper. The network helps show where Andrew H. Limper may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew H. Limper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pneumocystis Pneumonia Hit paper breakdown → | 2004 | 716 |
| 2 | Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Hit paper breakdown → | 1991 | 692 |
| 3 | Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy Hit paper breakdown → | 1996 | 464 |
| 4 | 2004 | 443 | |
| 5 | 2004 | 410 | |
| 6 | 2010 | 407 | |
| 7 | 1989 | 385 | |
| 8 | Fungal infections in HIV/AIDS Hit paper breakdown → | 2017 | 332 |
| 9 | 1999 | 296 | |
| 10 | 2000 | 295 | |
| 11 | 1990 | 294 | |
| 12 | 2009 | 282 | |
| 13 | 2002 | 268 | |
| 14 | 2003 | 268 | |
| 15 | 2017 | 219 | |
| 16 | 2007 | 189 | |
| 17 | 2005 | 188 | |
| 18 | Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability Hit paper breakdown → | 2023 | 159 |
| 19 | 1997 | 151 | |
| 20 | 2005 | 144 |
About Andrew H. Limper
Andrew H. Limper is a scholar working on Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine, Oncology and Organic Chemistry, having authored 291 papers that have together received 14.5k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (150 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (61 papers), Pneumonia and Respiratory Infections (53 papers), Antifungal resistance and susceptibility (45 papers), Peptidase Inhibition and Analysis (35 papers), Tuberculosis Research and Epidemiology (30 papers), HIV/AIDS drug development and treatment (27 papers) and Fungal Infections and Studies (22 papers). The work is most often cited by research in Infectious Diseases (3.7k citations), Epidemiology (6.1k citations), Pulmonary and Respiratory Medicine (4.3k citations), Immunology (1.3k citations) and Physiology (1.5k citations). Andrew H. Limper has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Charles F. Thomas, Joseph E. Standing, Thomas V. Colby, Theodore J. Kottom, Robert Vassallo, Eva M. Carmona, Steven H. Yale, Edward B. Leof, Jay H. Ryu and Craig Daniels. Their work appears in journals such as CHEST Journal, Infection and Immunity, American Journal of Respiratory Cell and Molecular Biology, American Journal of Respiratory and Critical Care Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.